Check out our most popular compounded medications! Get Started
Our Enrofloxacin 50 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and user-friendly alternative to solid dosage forms. This formulation is particularly beneficial for patients who experience difficulty swallowing pills, including those in pediatric and geriatric groups.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Enrofloxacin 50 mg/ml Oral Liquid is a custom-prepared medication designed for oral administration, specifically tailored to meet the needs of patients who may have difficulty swallowing pills or tablets, such as pediatric or geriatric patients. This formulation provides a precise 50 mg of enrofloxacin in each milliliter of liquid. Enrofloxacin is a fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and cell division in bacteria. This action results in the elimination of bacterial pathogens.
The Enrofloxacin 50 mg/ml Oral Liquid is particularly useful in treating infections of the urinary tract, skin, respiratory system, and gastrointestinal tract, as well as other systemic infections where enrofloxacin-sensitive bacteria have been identified. It is important for prescribers to consider the potential for bacterial resistance and to use this medication judiciously, reserving it for cases where other, less potent antibiotics are ineffective or contraindicated. Patients should be advised to complete the full course of therapy as prescribed, even if symptoms improve before the medication is finished, to prevent the development of resistance and ensure the infection is fully eradicated.
As with all medications, there may be potential side effects, including gastrointestinal upset, central nervous system effects, or hypersensitivity reactions. It is crucial for patients to be monitored for any adverse reactions, especially in populations with a higher risk of side effects, such as the very young, the elderly, or those with pre-existing medical conditions. Prescribers should be aware of the contraindications and drug interactions associated with enrofloxacin, including its potential to affect the metabolism of other drugs and its contraindication in patients with a history of quinolone hypersensitivity.
Bayview Pharmacy's team of compounding pharmacists ensures that each batch of Enrofloxacin 50 mg/ml Oral Liquid is prepared with the highest standards of quality and precision. We are committed to providing personalized care and are available to answer any questions or concerns regarding this formulation. If you have any questions or require further information about the Enrofloxacin 50 mg/ml Oral Liquid, please do not hesitate to reach out to us for professional advice and support.
Enrofloxacin 50 mg/ml Oral Liquid works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes necessary for DNA replication, transcription, repair, and recombination. This action leads to the death of the bacteria and resolution of the infection. Enrofloxacin is commonly used in veterinary medicine and is not approved for use in humans. It is important to note that the use of enrofloxacin in humans is off-label and should be done with caution and under the guidance of a healthcare professional.
When considering the use of enrofloxacin 50 mg/ml oral liquid, it is crucial to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects. Enrofloxacin can interact with several classes of drugs. For instance, concurrent use with antacids, sucralfate, or products containing iron or zinc can decrease the absorption of enrofloxacin, leading to reduced effectiveness. It is advisable to administer enrofloxacin at least 2 hours before or 6 hours after these agents.
Enrofloxacin may also interact with theophylline, a medication used to treat respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD). Enrofloxacin can inhibit the metabolism of theophylline, potentially leading to increased theophylline levels in the blood and a higher risk of theophylline-related side effects. Close monitoring of theophylline levels and adjustment of its dosage may be necessary when used concurrently with enrofloxacin.
Additionally, enrofloxacin can increase the risk of seizures when used with nonsteroidal anti-inflammatory drugs (NSAIDs) or other agents that lower the seizure threshold. Caution is advised when using enrofloxacin alongside these medications, especially in patients with a history of seizures or other central nervous system disorders.
Warfarin and other oral anticoagulants may have their effects potentiated by enrofloxacin, leading to an increased risk of bleeding. If co-administration is necessary, monitoring of prothrombin time or international normalized ratio (INR) should be performed, and dosage adjustments of the anticoagulant may be required.
It is also important to consider that enrofloxacin may interact with other antibiotics, particularly those that exhibit bacteriostatic activity. The concurrent use of enrofloxacin with drugs such as tetracyclines, macrolides, and chloramphenicol may result in antagonistic effects and should be avoided unless specifically recommended by a veterinarian.
Patients and prescribers should be aware that this is not an exhaustive list of all potential drug interactions with enrofloxacin. It is essential to provide a complete list of all medications, supplements, and over-the-counter products the patient is taking to the pharmacist or healthcare provider to ensure safe and appropriate use of enrofloxacin oral liquid. If you have any questions or concerns regarding the use of this formulation or potential drug interactions, please reach out to us at Bayview Pharmacy for further assistance.
The mechanism of action of enrofloxacin involves inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription. By doing so, it prevents the bacteria from replicating and transcribing DNA, leading to the elimination of the bacterial infection. This makes enrofloxacin a potent choice for treating diseases caused by susceptible strains of bacteria.
The 50 mg/ml oral liquid formulation of enrofloxacin is designed to provide a high concentration of the medication for ease of dosing, particularly in situations where precision is key. This liquid form is especially beneficial for patients who have difficulty swallowing pills, such as young children, the elderly, or those with dysphagia. The liquid formulation allows for flexible dosing, as it can be easily measured to provide the exact amount prescribed by a healthcare provider. Additionally, the liquid form can be more palatable and may be flavored to improve acceptance and adherence to the treatment regimen.
Enrofloxacin 50 mg/ml oral liquid is used to treat a variety of infections caused by susceptible bacteria. These may include respiratory infections, urinary tract infections, gastrointestinal infections, and skin infections, among others. The effectiveness of enrofloxacin in treating these disease states is contingent upon the pathogen being susceptible to the drug, as well as the drug reaching sufficient concentrations at the site of infection. It is important to note that fluoroquinolones, including enrofloxacin, should be used judiciously to minimize the risk of developing bacterial resistance.
For patients and prescribers considering the use of enrofloxacin 50 mg/ml oral liquid, it is crucial to follow the prescribed dosage and duration of treatment to ensure the best therapeutic outcomes. It is also important to be aware of potential side effects and drug interactions associated with enrofloxacin. As with any medication, monitoring for adverse reactions and effectiveness is essential. If you have any questions or concerns regarding the use of enrofloxacin 50 mg/ml oral liquid, or if you require further information about the formulation and its suitability for specific disease states, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure appropriate treatment for our patients.
Enrofloxacin 50 mg/ml Oral Liquid is an antibiotic medication used to treat infections caused by bacteria in pets, primarily in dogs and cats.
The liquid formulation should be given orally, directly into the pet's mouth or mixed with a small amount of food. It's important to adhere to the dosing instructions provided by the veterinarian for the duration of the treatment course, even if symptoms improve before finishing the medication.
Yes, Enrofloxacin Oral Liquid can be prescribed for both cats and dogs; however, the dosage may vary depending on the species, weight, and condition being treated. Always use the medication as directed by your veterinarian.
If a dose is missed, administer it as soon as you remember. However, if it's almost time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not give a double dose to make up for the missed one.
Some pets may experience side effects such as vomiting, diarrhea, or loss of appetite. More serious side effects include seizures or behavioral changes. If you observe any unusual symptoms or behaviors in your pet, contact your veterinarian immediately.
Store the medication at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use. Make sure it's kept out of reach of children and pets to prevent accidental ingestion.
Enrofloxacin might interact with other medications, so it's important to discuss all of your pet's current medications with your veterinarian to avoid potential drug interactions.
If you suspect your pet has been given too much Enrofloxacin, contact your veterinarian or an emergency veterinary clinic right away. Signs of overdose may include nausea, vomiting, or seizures.
Liquid formulations like Enrofloxacin Oral Liquid are often preferred for pets that have difficulty swallowing pills or tablets, or for those that are finicky eaters. The liquid can be easily measured for accurate dosing and mixed with food or given directly.
It's essential to complete the full course of antibiotics as prescribed by your veterinarian, even if your pet appears to have recovered. Stopping treatment early can lead to a relapse or the development of antibiotic-resistant bacteria.
While Enrofloxacin can be used in many breeds of dogs and cats, certain breeds may be more sensitive to this drug. Your veterinarian will be able to tell you if Enrofloxacin is the right choice for your pet based on their health history and breed.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
